Key risks
- Profitability metrics (PE, ROE, OPM) and leverage (D/E) not disclosed, preventing assessment of returns and financial risk
- Stock volatility (52-week range ₹56.53–₹124, 2.2x range) indicates operational or market uncertainty
- FII shareholding declined sharply from 2.39% (Dec 2025) to 0.56% (Mar 2026), potentially signaling institutional skepticism
- Healthcare faces regulatory and reimbursement risks; review recent filing (2026-08-14) for material impacts
Generated analysis · source review pending